- Premium Stock Alerts
- Posts
- Fed + Volume Surge = Today's Hottest Stocks!
Fed + Volume Surge = Today's Hottest Stocks!
Noor Saba
March 22, 2024
Don’t want emails from us anymore? Click here to unsubscribe
Hello Part-time Trader…👋
Premium Stock Alerts is here with your pre-market cheat sheet. In today's issue, we delve into:
Fed's Latest Announcements: Understand the Federal Reserve's recent decisions and economic outlook, and how they might influence the markets.
Volume Anomalies: Identify stocks witnessing unusual trading volumes, pointing to potential opportunities or risks.
Top Pre-Market Movers: Identify early winners poised for a strong market opening.
Market Indices & Sector Overview: Get a snapshot of key market indices and sector performances to gauge the day's potential trends.
FDA Approvals & Upcoming Decisions: Keep an eye on the latest FDA approvals and crucial upcoming decisions affecting biotech and pharmaceutical stocks.
Now, let's dive into today's edition for a closer look at the insights and analysis that will shape your trading decisions.
Sponsored
Today's #1 Stock To Buy
This high-flying stock is priced between $1 and $10 with huge upside potential. It has a new buy signal today! Don't miss out on this stock.
Get This Top Stock Now
Happening Today
✓ 09:00 AM ET – Fed Chair Powell Speaks
✓ 12:00 PM ET – Fed Vice Chair for Supervision Barr Speaks
✓ 01:00 PM ET – U.S. Baker Hughes Oil Rig Count
✓ 01:00 PM ET – U.S. Baker Hughes Total Rig Count
PREMARKET SNAPSHOT 📈
Stock futures point to a positive open as the Dow surges 0.68%, followed by the NASDAQ and S&P 500.
S&P500$5,241.53 ⬆️ 0.32% | Dow$39,781.37 ⬆️ 0.68% | NASDAQ$16,401.84 ⬆️ 0.2% |
SECTOR SNAPSHOT ✨
Financials and Industrials power the market today, with gains exceeding 0.85% and 1.00% respectively. Energy and Materials follow suit with moderate increases. Tech holds steady with a minor gain, while Utilities and Communication Services see slight declines.
NAME | PRICE | %CHANGE |
|---|---|---|
Consumer Discretionary | 1,484.43 | +0.46% 🟢 |
Consumer Staples | 811.31 | +0.04% 🟢 |
Energy | 707.12 | +0.54% 🟢 |
Financials | 697.98 | +0.85% 🟢 |
Health Care | 1,699.25 | +0.11% 🟢 |
Industrials | 1,063.94 | +1.00% 🟢 |
Materials | 579.25 | +0.40% 🟢 |
Real Estate | 245.79 | +0.43% 🟢 |
Information Technology | 3,852.51 | +0.14% 🟢 |
Communication Services | 284.03 | -0.17% 🔴 |
Utilities | 323.87 | -0.21% 🔴 |
Sponsored
2-Minute Trade Test: Avoid Losses with Proven Strategy!
Discover the secrets that Wall Street guards! discover the secrets that wall street guards in our exclusive guide, distilled from 40 years of trading wisdom, reveals how to help you predict a losing trade in just 120 seconds. Don't miss out on this game-changing technique. Unlock your trading potential and help safeguard your investments now.
Get your free copy today and trade with confidence!
Unusual Volume
📈 Yield10 Bioscience Inc (YTEN) jumped 78.85% to $0.43 on a whopping 116.79 million shares traded after it declared its genetically modified Camelina plants, rich in omega-3s, cleared for growing and breeding in the US by USDA.
📈 Investors went wild, sending Faraday Future Intelligent Electric Inc (FFIE) stock soaring 48.63% to $0.14 on a massive volume of 102.81 million shares.
📈 Abnormal activity shook Kaival Brands Innovations Group Inc (KAVL), pushing it up 118.80% to $2.91 on a whopping 97.52 million shares traded.
📈 Micron Technology Inc. (MU) stock recently closed 14.13% upper at $109.85 on substantial volume of 89.55 million shares. This unusual activity came after the company revealed results for its second quarter of fiscal 2024, which ended February 29, 2024.
📈 Lufax Holding Ltd ADR (LU) increase by 45.70% in a single trading session, with abnormally high trading volume of 54.72 million shares following the release of the company’s fourth quarter 2023 earnings report.
Sponsored
Unlock March's Top 5 Stocks Poised for Exceptional Gains!
As March unfolds, the investment horizon brims with opportunity. Don't miss out on the chance to elevate your portfolio with our expertly curated list of 5 stocks. These picks are not just promising; they're positioned to potentially deliver substantial returns in the dynamic market landscape of 2024.
With a keen eye on innovation and growth potential, our selection is designed to secure your spot at the forefront of this month's investment wave. Act now to gain exclusive access to these high-potential stocks and watch your investments thrive. Time is of the essence - secure your financial future today!
Click here to unveil the stocks that are set to soar.
Premarket Movers
BIOL (BIOLASE, Inc.): Surges 33.27% on 7.80M shares traded, following the release of full-year 2023 results.
BEAT (HeartBeam, Inc.): Gains 12.99% on 87.57K shares, after releasing fourth quarter and full year 2023 financial results.
KULR (KULR Technology Group, Inc.): Jumps 5.13% on 81.88K shares, after announcing the receipt of an additional purchase order from the United States Army, increasing the total contract value to $1.81 million.
Pre Market Gainers | Pre Market Change | Pre Market Volume |
|---|---|---|
BIOL | +33.27% | 7.80M |
NVFY | +67.57% | 1.31M |
GOEV | +5.07% | 363.98K |
AULT | +3.54% | 162.88K |
IVP | +5.25% | 122.48K |
UCAR | +2.78% | 101.33K |
BEAT | +12.99% | 87.57K |
KULR | +5.13% | 81.88K |
SMR | +2.63% | 76.19K |
OCGN | +8.96% | 53.01K |
Sponsored
$50 trade to make today with huge potential!
My favorite trade is an overnight options trade with just $50 or so bucks. I look for a precise setup that has delivered 300%+ gains overnight in the past. I'll show this trade for free in my brand-new presentation I just released. These overnight trades are a ton of fun to put on, easy to do on the side, and you close them fast. The next trade comes out on Thursday.
Click here to access my #1 options strategy for overnight wins starting with $50!
Important FDA
Recently Announced
Orchard Therapeutics plc (ORTX) reached a milestone in pediatric healthcare as the FDA approved its gene therapy, OTL-200, known as Lenmeldy, for treating metachromatic leukodystrophy in children, announced on March 18, 2024.
OptiNose Inc. (OPTN) expanded the usage of its XHANCE nasal spray by securing FDA approval on March 15, 2024, for treating chronic rhinosinusitis in adults.
Upcoming this Week
Merck & Co Inc. (MRK) awaits FDA's decision on Sotatercept for adult pulmonary arterial hypertension, seeking enhanced treatment options.
Akebia Therapeutics, Inc. (AKBA) looks forward to the outcome of its Vadadustat NDA resubmission on March 27, 2024, targeting anemia in CKD patients undergoing dialysis.
Esperion Therapeutics (ESPR) eagerly awaits FDA's decision on NEXLIZET by March 31, 2024, focusing on cardiovascular risk reduction and expanding indications for LDL-C lowering, with the aim of improving patient outcomes.
🎁 Looking for More? Check out these complementary newsletters for diverse perspectives:
|
|
|
Happy investing,
Maeve Grace
Editor In Cheif
Premium Trade Alerts
Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.
Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.
Reply